Distinct protein assemblies are nucleated at telomeric DNA to both guard the ends from damage and lengthen the DNA after replication. In yeast, Cdc13 recruits either Stn1-Ten1 to form a protective cap or the telomerase holoenzyme to extend the DNA. We have established an in vitro yeast telomere system in which Stn1-Ten1-unextendable or telomerase-extendable states can be observed. Both assemblies are Cdc13 dependent, as the Cdc13 C-terminal region supports Stn1-Ten1 interactions and the N-terminal region contains a telomerase-activation function. Notably, the yeast Hsp90 chaperone Hsp82 mediates the switch between the telomere capping and extending structures by modulating the DNA binding activity of Cdc13. Taken together, our data show that the Hsp82 chaperone facilitates telomere DNA maintenance by promoting transitions between two operative complexes and by reducing the potential for binding events that would otherwise block the assembly of downstream structures.
Telomeres are heterogeneous nucleoprotein assemblies localized at eukaryotic chromosome termini. They both protect the ends from damage and extend the DNA length after replication. To accomplish these activities, various proteins are nucleated at telomeric DNA to form distinct structures, including capping and extending complexes 1, 2 . The exact composition of each assembly is not entirely understood, but genetic analysis in the budding yeast Saccharomyces cerevisiae has revealed many crucial components, including EST2, STN1, TEN1 and CDC13. EST2 encodes the telomerase reversetranscriptase subunit that extends telomeric DNA; the Stn1 and Ten1 proteins cap the chromosome ends. Cdc13 promotes both DNA extension and protection: in vivo studies support a model in which Cdc13 recruits and stabilizes both the Est2 extending and Stn1-Ten1 capping structures [3] [4] [5] [6] [7] . The telomere protein system functions effectively in vivo, despite a common binding specificity for singlestranded telomeric DNA by Cdc13, Stn1-Ten1 and telomerase 4, 8, 9 . It remains unclear why the proteins do not interfere with each other, how transitions between the two telomere structures are mediated and how Cdc13 is involved in the seemingly opposed telomere activities of capping and extending.
In addition to Cdc13, the yeast Hsp90 molecular chaperones Hsp82 and Hsc82 affect both capping and extending components. Hsp82 and Hsc82 are high-copy suppressors for the capping mutants stn1-1 and cdc13-1, yet in a wild-type background elevated chaperone levels result in shortened telomeric DNA 10 . Neither the mechanism for the suppression nor the reduced telomere DNA length after Hsp82 overexpression in wild-type cells is understood. In contrast, the means by which Hsp82 modulates telomerase has been revealed. Human HSP90 was the first telomerase cofactor discovered to directly influence DNA extension activity in vitro 11 ; work on the yeast system showed that Hsp82 promotes both telomerase DNA binding and nucleotide affinity during DNA extension 12 . Hence, Hsp90 chaperones affect both capping and extending telomere components, although the mechanistic contributions to the capping factors have yet to be revealed.
We sought to test directly whether the Hsp82 molecular chaperone functions with Cdc13 alone or in association with Stn1 and Ten1, by establishing the functional effect of Cdc13 alone and in conjunction with Stn1-Ten1 in vitro, examining whether Hsp82 affects the different protein assemblies and determining how a switch occurs between two operative telomere-protein states.
RESULTS

Cdc13 stimulates telomerase DNA extension activity
We first determined the effect of Cdc13 on telomerase DNA extension activity in vitro. We anticipated that Cdc13 would inhibit telomerase function by competing for the DNA substrate, as observed for the human Cdc13 ortholog POT1 (ref. 13 ). To discriminate between Cdc13 DNA binding-dependent effects, we used DNA substrates with either 23-nucleotide (nt) or 7-nt 3¢ overhangs in the telomerase extension assays. Previous biochemical studies indicated that Cdc13 requires a minimum of 11 single-stranded nucleotides to bind DNA 14 . In accordance, our Cdc13 protein did not bind to DNA with a 7-nt 3¢ overhang but did bind to a 22-nt overhang substrate (Supplementary Fig. 1 ). Unexpectedly, Cdc13 activated telomerase DNA extension activity independently of the length of the 3¢ overhang DNA (Fig. 1a) . The DNA products below the +1 position for the 23-nt substrate are likely to have been produced by a previously described telomeraseassociated endonuclease activity 15 .
Cdc13 enhanced the extension of the 23-nt substrate to a greater extent than it did the 7-nt 3¢ overhang DNA (B18-fold versus B9-fold, respectively), suggesting that DNA binding by Cdc13 contributes positively to telomerase activity. Nonetheless, Cdc13 activation of the 7-nt substrate suggests that Cdc13 affects telomerase independently of direct DNA binding. Notably, Cdc13 assembled with telomerase, or potentially some other RNase-sensitive component of the extract on 7-nt or 22-nt 3¢ overhang substrates, but the 7-nt DNA structure was dependent on the DNA binding activity of telomerase, suggesting that Cdc13 tethers to the DNA-bound enzyme ( Fig. 1b) . Although stimulation by Cdc13 contrasts with the inhibitory effect of POT1, POT1 activates telomerase in conjunction with the telomeric protein TPP1 (ref. 16 ). Hence, Cdc13 seems to function in a manner comparable to the combined effects of POT1 and TPP1.
The Cdc13 N terminus has a telomerase-activation function To better understand how Cdc13 regulates telomerase activity, we produced and characterized a series of Cdc13 protein derivatives: fulllength Cdc13, a Cdc13-2 point mutant, the DNA binding domain (DBD), the N terminus through the DBD (N domain) and the DBD through the C terminus (C domain) ( Fig. 2) . All derivatives showed high-affinity DNA binding activity (data not shown). Full-length Cdc13, Cdc13-2 and the N domain activated telomerase DNA extension activity on either DNA substrate. Hence, in addition to its suggested telomere-recruitment function 6 , the Cdc13 N terminus has a telomerase-activation surface. In contrast, the C domain and DBD derivatives inhibited extension of the 23-nt substrate but did not affect basal extension of the 7-nt 3¢ overhang DNA (Fig. 2) .
The ability of Cdc13-2 to stimulate telomerase indicated that the upregulation does not involve interactions with the holoenzyme component Est1, as the Cdc13-2 mutation disrupts Cdc13-Est1 interactions and is likely to be distinct from the Cdc13 telomererecruitment function 7 . We believe that the observed telomerase activation potential is likely to occur downstream from nucleation of telomerase to a telomere in vivo. The positive effect of the N domain on telomerase extension activity might account, in part, for the increased telomere DNA length in cdc13-5 yeast 6 . Assuming telomerase remains engaged to the telomere after a single Cdc13mediated recruitment event, an additional Cdc13 function would be required to not only account for the hyperelongation of the DNA in the cdc13-5 background, but also to counter the DNA attrition that would be anticipated by loss of the C-terminal Stn1-interaction site 17 .
In contrast to activation, telomerase inhibition by the C-domain and DBD fragments was dependent on the length of the single-stranded DNA, which suggests that the decline in activity is likely to result from competitive binding to the DNA substrate. If these suppositions are correct, proper telomere regulation in vivo would require a mechanism to prevent Cdc13 from competing with telomerase for DNA binding without interfering with Cdc13regulatory capabilities.
Cdc13 and Stn1-Ten1 form an unextendable DNA structure In addition to Cdc13, Stn1 and Ten1 serve in telomere capping in vivo 1 . To determine whether full-length Cdc13 functions with Stn1 and Ten1, we purified the proteins ( Supplementary Fig. 2a ) and tested their effects on telomerase activity. In the presence of Cdc13, we observed a marked reduction in DNA extension with increasing Stn1-Ten1 levels, using the 23-nt 3¢ overhang DNA but not the 7-nt substrate ( Fig. 3a and Supplementary Fig. 2b ). In the absence of Cdc13, Stn1-Ten1 had no apparent effect on DNA extension (Fig. 3a) . The point mutant Cdc13-2, which does not interact with Stn1 in vivo 6 , did not repress telomerase activity with Stn1-Ten1 in vitro (Fig. 3b) , indicating that the Stn1-Ten1 interaction is specific for wild-type Cdc13. Our in vitro data support recent in vivo work suggesting that Cdc13 and Stn1 block telomerase action at a telomere 18 .
The negative effect of the DBD and C domain fragments on telomerase activity complicated our ability to assess whether these proteins can form an Stn1-Ten1 cap structure, as DNA extension activity is suppressed in the absence of supplemental Stn1-Ten1. To determine which Cdc13 domain assembles with Stn1-Ten1 on DNA, we conducted fluorescence anisotropy DNA binding experiments. Both full-length Cdc13 and the C domain associated with Stn1-Ten1 on DNA in vitro ( Fig. 3c ), which agrees with previous genetic data indicating that the C terminus interacts with Stn1 to protect telomere ends in vivo 17 . In contrast, neither the N domain nor Cdc13-2 assembled with Stn1-Ten1 on DNA in vitro ( Fig. 3c Figure 1 Cdc13 stimulates telomerase DNA extension activity independent of single-stranded 3¢ overhang DNA length. (a) The effect of Cdc13 on telomerase-mediated DNA extension was determined using DNA substrates with either 23-nt or 7-nt 3¢ overhangs and Cdc13 protein titration (50, 100, 250, 500 and 1,000 nM). To control for possible nonspecific protein effects, the impact of BSA (B; 1,000 nM) addition was tested. All reactions were supplemented with a loading control primer (arrow) before precipitation and electrophoresis. The +1 position for each DNA substrate is indicated. (b) Cdc13 can tether to DNA-bound telomerase. Fluorescence anisotropy with a fluorescein-labeled telomeric oligonucleotide was used to detect DNA association. The ability of Cdc13 to join DNA-bound telomerase was determined by adding purified Cdc13 (250 nM) to telomerase-DNA complexes using the 22-nt or 7-nt DNA substrates. To show telomerasedependent DNA binding, RNase A treatment was included 19 . The quantified data represent mean ± s.d. from five independent assays.
3′ overhang 23-nt 7-nt Figure 2 The N-terminal domain of Cdc13 has a telomerase-activation function. The effects of 250 nM full-length (FL) Cdc13, Cdc13-2 (2), N domain (N), C domain (C) or DNA binding domain (DBD) on telomerase DNA extension using 7-nt or 23-nt 3¢ overhang DNA substrates were determined. All reactions were supplemented with a loading control primer (arrow) before precipitation and electrophoresis. The +1 position for each DNA substrate is indicated.
results were observed using an electrophoretic mobility shift assay ( Supplementary Fig. 2c ). Hence, Cdc13 has three distinct domains: an N-terminal telomerase activation region, a central DNA binding domain and a C-terminal Stn1-Ten1-interaction site.
Hsp82 switches the state from unextendable to extendable The ability of the DBD and C domain to interfere with DNA extension indicates that Cdc13 DNA binding activity is sufficient to inhibit telomerase, but, unless Stn1-Ten1 is present, full-length Cdc13 functions only as an activator. To account for these results, we hypothesized that a telomerase cofactor was present in the reactions, preventing Cdc13 from interfering with telomerase but permitting DNA-bound telomerase to associate with Cdc13. Given the established roles of Hsp82 in capping and extending telomere components, we tested whether Hsp82 affects Cdc13. As an initial test, we titrated Hsp82 into DNA extension reactions containing a Cdc13-Stn1-Ten1capped telomeric DNA substrate ( Fig. 4a ). In the absence of supplemental Hsp82, Cdc13-Stn1-Ten1 suppressed the DNA extension activity below basal levels ( Fig. 4a, lanes 1 and 3) . However, the extension activity increased B15-fold in an Hsp82-dependent manner, indicating that Hsp82 is sufficient to switch the Cdc13-Stn1-Ten1 capping structure into a Cdc13 telomerase-extending complex ( Fig. 4a ).
To investigate how Hsp82 affects the protein-DNA complexes, we determined the effect of Hsp82 on the DNA binding activities of the Cdc13 derivatives. Hsp82 dissociated full-length Cdc13 and the N domain from DNA, but the chaperone did not extensively affect DNA binding by the DBD or C domains ( Fig. 4b ). Hence, Hsp82 modulates Cdc13 through interactions with the N terminus. In addition to direct DNA binding, Cdc13 and the DBD fragment protected single-stranded DNA from nuclease digestion (Supplementary Fig. 3 ). However, in the presence of Hsp82, the full-length Cdc13 no longer protected the DNA. On the basis of the anisotropy data, Hsp82 showed a higher affinity for the N domain (K d , B35 nM) than for full-length Cdc13 (K d , B325 nM), suggesting that contacts between the N and C domains of Cdc13 affect modulation by Hsp82. In contrast to Hsp82, Sba1 had no apparent effect on Cdc13 DNA binding ( Fig. 4b) , despite the ability of Sba1 to dissociate telomerase from DNA 19 .
Notably, Hsp82 actively prevented Cdc13 DNA binding, as Cdc13 binding activity was restored after inhibition of Hsp82 with the small molecule radicicol (Fig. 5a ). Furthermore, treatment of telomerase extract with radicicol resulted in Cdc13-mediated suppression, rather than activation, of telomerase activity using the 23-nt substrate ( Fig. 5b) . Thus, Hsp82 specifically converts the Cdc13 capping structure into a Cdc13 telomerase-extending complex by interfering with DNA binding by Cdc13 but not with its ability to associate with DNA-bound telomerase. In addition, alternate stepwise addition of Hsp82 and Stn1-Ten1 revealed a competitive equilibrium effect on DNA binding activity in vitro (Fig. 5c) Cdc13 mechanism to reestablish a Cdc13 DNA-bound state, which has important implications for Cdc13-mediated DNA structures.
Hsp82 modulates Cdc13 activities in vivo
Given the impact of Hsp82 on Cdc13 in vitro, one might predict that Hsp82 overexpression would have a marked effect on telomere DNA length in vivo. However, our studies ( Supplementary Fig. 4a ) and previous work 10 indicate that ectopic Hsp82 overexpression results in an B50% reduction in telomere DNA length. Although the change in DNA length is associated with the relative increase in Hsp82 protein amounts ( Supplementary Fig. 4a ), the modest telomere effect might also occur if Hsp82 affects competing telomere functions. For example, an increase in cellular Hsp82 might lower Cdc13-mediated DNA end protection by limiting formation of capping complexes; however, a reduction in Cdc13 DNA binding would promote telomerase-DNA interactions by elevating telomerase accessibility to the extreme 3¢ DNA end. To test this model, we examined the effect of Hsp82 on cell-cycle telomere occupancies by Cdc13 and telomerase and on telomere capping and extending activities. Telomere association by Cdc13 declined after Hsp82 overexpression throughout the cell cycle, except during late S phase (Fig. 6a ). This occupancy pattern was predicted by our in vitro data. Cdc13 telomere interactions were reduced during cell-cycle phases associated with capping events but were unaffected at late S phase, when Cdc13 would activate telomerase by tethering to the DNA-bound enzyme. To determine whether the decline in Cdc13 telomere occupancy affects DNA end protection, we examined whether the relative levels of single-stranded TG 1-3 DNA repeats fluctuate with Hsp82 expression using an in-gel native Southern blot assay 20, 21 . As expected, TG 1-3 signal increased in yeast overexpressing Hsp82 ( Supplementary Fig. 4b ), suggesting that DNA end protection declines with increased Hsp82 protein in vivo.
In contrast to Cdc13, Est2 telomere interactions did not change appreciably with Hsp82 expression, except for a modest but reproducible (albeit statistically insignificant) increase in late S phase ( Fig. 6b) . Minimally, the data show that additional Hsp82 does not interfere with the ability of Cdc13 to efficiently recruit telomerase to telomeres. We suspect that the mild rise in Est2-telomere association resulted from an increase in direct DNA binding by telomerase-that is, Est2-DNA cross-linking efficiency increased as more Est2 came in direct contact with the DNA. If elevated Hsp82 levels do facilitate telomerase access to the telomeric DNA, there might be an increase in telomere DNA extension rates, as telomerase would now be directly engaged with the DNA.
To investigate telomere DNA lengthening activity, we used an established, engineered yeast strain that permits controlled, rapid reduction in telomere DNA length and assessment of telomerase DNA extension rates in vivo 22 . In brief, the left arm terminus of chromosome VII contains an internal telomere tract that is flanked by Flp1-recognition target sites; the tract is specifically removed after (c) Telomeric DNA extension is Hsp82 dependent. Above, elongation of inducibly truncated telomeric DNA was monitored in yeast with endogenous (Endo, E) or overexpressed (Over, O) Hsp82. Quantified data represent mean ± s.d. from five independent assays. The mean number of nucleotides added to the shortened telomeric DNA was determined using an established protocol 22 . Below, cell samples were removed for DNA extraction before the addition of galactose (P), after galactose addition but before removal of a-factor (0) and after a single cell cycle after removal of a-factor. M, marker. A full view of the Southern blot is shown in Supplementary Figure 5 .
transient Flp1 expression, and DNA elongation can be monitored in subsequent cell divisions. To limit the effects of Hsp82 on capping events, we induced Hsp82 overexpression in conjunction with Flp1 while the yeast cells were under a-factor-induced cell-cycle arrest. This permitted a focus on the DNA extension levels achieved during the first cell cycle after the Flp1-mediated telomeric DNA reduction. In the presence of elevated Hsp82 protein levels, the extension length was faster (approximately five-fold) than in yeast with endogenous Hsp82 levels (Fig. 6c ). There are a number of possibilities for the increased DNA lengthening, including direct effects on telomerase activity by Hsp82 (ref. 12 ), but we suggest that the change also involves modulation of Cdc13 DNA binding by Hsp82. In brief, we propose that the telomerase-mediated DNA extension increases because Hsp82 inhibits assembly of the unextendable telomere structure (that is, it reduces steric interference by Cdc13) without disrupting positive Cdc13 functions (telomere recruitment and activation). Taken together, our data suggest that steady-state telomere DNA length is reduced after Hsp82 overexpression owing to a decline in capping activities. However, the magnitude of the shortening is limited because telomerase accessibility to the telomeric DNA has increased, and telomerase-mediated DNA extension is therefore enhanced, which counters the impact of the declined telomere capping.
DISCUSSION
Here we provide a potential resolution to the apparent conundrum of how proteins with identical binding specificities coordinately function at a single site. DNA binding proteins often form long-lived complexes with target DNA in vitro, which would interfere with the assembly of other structures; telomere-protein assemblies are no exception 2 . For example, a stable Cdc13-telomere association at the extreme 3¢ DNA end would block telomerase DNA binding, but Cdc13 binding at the extreme termini is likely to be required to protect the DNA from degradation in vivo. Our data support a model in which Hsp82 frees the DNA end of competing binding proteins without interfering with crucial regulatory events. In our model, telomerase recruitment to a telomere is initiated through transient contacts between Cdc13 and the holoenzyme (Fig. 7) . To permit proper telomerase DNA association, Hsp82 displaces proteins bound at the extreme 3¢ DNA end, including Cdc13. Recent genetic studies highlight the potential importance of maintaining a dynamic telomere environment, as the peak of telomere association by Cdc13, Stn1 and Est1 all occur in S phase 18, 23 . Presumably, both capping (Stn1) and extending (Est1) proteins are recruited to the telomere each S phase, as not all telomeres are extended each cell cycle 24 . Hence, depending on the DNA length of a particular telomere, a molecular choice is made to either permit or preclude telomerase function (that is, to build an Est1-extending or Stn1-capping complex, respectively). If Hsp82 maintains Cdc13 in a dynamic DNA binding cycle, then any modifications (such as phosphorylation) meant to guide a telomere to a distinct operative phase would be immediately incorporated.
Recent genetic studies suggest post-translational modifications mediated by the Tel1 (ATM homolog) and Cdk1 kinases are crucial for proper telomere DNA maintenance 25, 26 . For example, Tel1 is recruited to critically short telomeric DNA tracts, which are preferentially elongated, and Cdc13 has been shown to be a Tel1 target 25, 27 . In addition, Cdk1 phosphorylates Cdc13, and this modification seems to influence the preference between Stn1-and Est1-containing Cdc13nucleated telomere complexes 26 . Hence, depending on the phosphorylation state of Cdc13, telomeric DNA would be in a Cdc13-Stn1-Ten1 unextendable state or a Cdc13-Est1-telomerase extendable state. Dynamic Cdc13 action, mediated by Hsp82, would enable the telomere system to rapidly transition between the two structures as needed.
In addition to protein dynamics, our studies reveal a telomeraseactivation function of Cdc13, which may account for the telomerelengthening phenotypes resulting from several cdc13 mutations 5,6 . Of note, the Cdc13 telomerase-stimulation activity that we observed is in stark contrast to a recent report showing telomerase inhibition by fulllength Cdc13 (ref. 28) . Currently, the reason for the different effects of full-length Cdc13 on telomerase activity is unclear. We did find that Cdc13's activation function was lost after a brief (5 min) incubation at 42 1C, whereas its DNA binding activity was unaffected (data not shown), suggesting that the conformation of the activation surface is labile. Perhaps by expressing full-length Cdc13 in a specialized streptomycin-resistant bacterial strain, which was crucial for obtaining soluble recombinant protein (E. Siller, D.C.D., J.F. Anderson, B.C.F. & J.M. Barral, unpublished data), we provided the activation surface an opportunity to properly fold. In contrast to the data on full-length Cdc13, both studies (the present study and ref. 28 ) observed telomerase inhibition by the Cdc13 DBD fragment, which showed no apparent difference when expressed in either classic or streptomycinresistant bacterial cells (E. Siller, D.C.D., J.F. Anderson, B.C.F. & J.M. Barral, unpublished data).
Nevertheless, previous genetic data suggest a role for Cdc13 with telomerase that is downstream of telomere nucleation. For example, the cdc13-4 yeast has short but stable telomeric DNA, despite an apparent capacity of Cdc13-4 to recruit telomerase to telomeres and protect the DNA from degradation 29 . Although the affected residue (P235S) occurs within the N-terminal domain, the mechanism for the telomere defect has not been identified. However, the in vivo phenotype is consistent with a post-recruitment function for Cdc13 (ref. 29) . Notably, the Cdc13-109 and Cdc13-231 mutants lead to overelongated telomeric DNA, despite a decline in DNA binding activity 5 . If the sole positive function of Cdc13 were to recruit telomerase to a telomere, then a decline in DNA binding would result in shorter, not longer, telomeric DNA. Additionally, the hyperelongation of telomeric DNA in the cdc13-5 yeast is consistent with a post-recruitment role for Figure 7 Hsp82 mediates telomere-protein dynamics. Cdc13 recruits select proteins to telomeric DNA, including Stn1-Ten1 and telomerase-Est1. As the independent structures form stable and long-lived interactions with telomeric DNA, transitions between the distinct complexes require molecular chaperone-mediated disassembly 2, 19 . Specific post-translational modifications would then guide the assembly of the requisite structure, which minimally would vary with the phase of the cell cycle. For example, phosphorylation of Cdc13 by Cdk1 and/or Tel1 would promote telomerase nucleation and DNA extension events 25, 26 .
Cdc13. The Cdc13-5 protein (N domain) consists of the N terminus and DNA binding domain 6 . In the absence of the Cdc13 C-terminal Stn1-interaction site, the telomeric DNA should be vulnerable to nuclease attack; however, the telomeric DNA is not degraded in the cdc13-5 yeast, but rather is overelongated 6 . We suggest that, in addition to recruiting telomerase, Cdc13-5 activates telomerase not only to hyperextend the DNA but also to counter any potential DNA degradation. Of note, the stimulatory function is downstream from Cdc13-mediated recruitment, as the effect is abrogated when combined with the Cdc13 point mutation cdc13-2 (cdc13-2,5) 6 . Taken together, established genetic data support our contention that Cdc13 modulates the DNA-bound enzyme. We suggest that telomerase cofactors, including Cdc13, are likely to re-engage the telomere protein assembly by tethering to the DNA-bound telomerase enzyme. A chaperone-mediated protein dynamics model has been previously proposed for transcription pathways 30 . In brief, molecular chaperones promote a dynamic action for transcription factors that is necessary to permit rapid functional recruitment of multiple coactivating complexes to a gene promoter. An important distinction, however, is the impact of the Hsp90 chaperone: Hsp90 promotes DNA binding by transcription factors but facilitates dissociation of Cdc13-DNA complexes. The dual role for Hsp82 at telomeres may provide an explanation for the difference. By exploiting the telomerase-associated cofactor Hsp82 to both support telomerase function and to clear the telomeric DNA of competing proteins, an elegant means to ensure telomeric DNA extension within the short working period allotted telomerase at the end of S phase is provided.
Hsp90 has traditionally been viewed as a cytoplasmic molecular chaperone required for the late folding stages of signaling molecules 31 . However, recent studies including high-throughput screens have identified a broad range of potential nuclear client proteins 2 . Given the impact of Hsp90 and Hsp82 on telomeric and transcriptional targets, there seems to be a general cellular role for Hsp90 chaperones in controlling protein-DNA dynamics. In brief, multistep pathways, including the telomere system, move forward through high-affinity interactions between the low-abundance proteins unique to that system (such as Cdc13, telomerase and Stn1), whereas proper structure composition (competitive interactions) and efficient transitions between different assemblies are mediated by transient, low-affinity interactions with the highly abundant molecular chaperones.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
ONLINE METHODS
Protein purification. We expressed the Cdc13 protein derivatives (pET28) and Stn1 (pETDuet1) protein as N-terminal His 6 fusions using T7 expression vectors in streptomycin-resistant CH184 Escherichia coli cells. Protein expression in the CH184 background alleviated solubility problems associated with Cdc13 and Stn1-Ten1. We coexpressed and copurified Ten1 (pETDuet1) protein with the His 6 -tagged Stn1. We expressed Hsp82 as an N-terminal His 6 fusion using a T7 expression vector (pET28) in codon-optimized Rosetta E. coli cells (Novagen). For the telomeric proteins, we grew the cells at 18 1C. We seeded LB medium lacking streptomycin to an optical density at 595 nm of 0.2 with transformants from an overnight culture grown in LB supplemented with streptomycin (0.2 mg ml -1 ). We then grew the cells to an optical density at 595 nm of 0.8. We induced protein expression with IPTG and incubated the cells for an additional 4 h. For Hsp82 expression, we grew the cells in a similar manner, except that we did not use streptomycin in the overnight seed culture, and we incubated the cells at 24 1C. After IPTG induction, we clarified the cultures by centrifugation, resuspended them in ice-cold 1Â Talon binding buffer, and snap-froze them. We added NP-40 (1% (v/v) final) to the Cdc13 preparations. We purified the proteins using metal-affinity chromatography (Talon resin) per the manufacturer's instructions (Clontech). We further resolved the telomeric proteins over MonoQ anion exchange resin and a Superdex-200 size-exclusion column (GE Healthcare). We purified Hsp82 as previously described 12 . We confirmed the identities of the purified proteins by MS and western blot analysis.
Telomerase DNA extension assays. We prepared telomerase extracts using wild-type (YPH499) S. cerevisiae and carried out telomerase DNA extension reactions as described 19 . In brief, the DNA extension reactions used MonoQ telomerase extract in extension buffer (50 mM Tris (pH 8.0), 1.0 mM MgCl 2 , 1.0 mM spermidine, 1.0 mM DTT, 0.5% (v/v) glycerol, 50 mM dTTP, 20 mCi [a-32 P]dGTP) with 2.0 pmol of telomeric DNA substrate immobilized on paramagnetic beads and supplemented with the indicated proteins. After cleavage of the DNA substrates with EcoRI, we magnetically separated the released DNA fragments from the beads, added an end-labeled precipitation and loading control primer, subjected the DNAs to ethanol precipitation, reconstituted the products in formamide-NaOH loading buffer, subjected them to denaturing gel electrophoresis and visualized them using a PhosphorImager (Molecular Dynamics).
Fluorescence anisotropy assay. We performed the anisotropy reactions in 25-ml volumes containing TMG-30 (20 mM Tris (pH 8.0), 1.1 mM MgCl 2 and 30 mM sodium acetate (pH 7.0)) supplemented with a fluorescein-labeled telomere oligonucleotide (12.5 nM; fl-GTGGGTGTGTGTGTGGGGTGGTGT GTGTGG). To form the hybrid single-and double-stranded DNA substrates, we annealed shorter complementary oligonucleotides to the 5¢ end of the telomere primer with a 7-nt (CACCACCCCACACACACACCCAC), 15-nt (CACACACACACCCAC) or 22-nt (ACACCCAC) 3¢ overhang. We incubated the reactions for 5 min at 25 1C before determining the anisotropy values using an Ultra Evolution plate reader (Tecan). We determined the RNase sensitivity of telomerase DNA binding by preincubating aliquots of the MonoQ extracts with 10 mg of RNase A for 10 min at 22 1C (ref. 19 ). All anisotropy data represent mean ± s.d. from five independent assays.
Chromatin immunoprecipitation assay. We conducted chromatin immunoprecipitation analysis essentially as described 19 . For the cell cycle experiments, we arrested yeast in late G 1 with a-factor (10 mg ml -1 ). After a 2-h incubation, we clarified the cultures by centrifugation and resuspended them in rich medium lacking a-factor to allow synchronous progression through the cell cycle at 30 1C. We removed aliquots to monitor cell-cycle synchronization by flow cytometry and budding assay, or treated them with formaldehyde (1% (v/v) final). To determine the relative telomere occupancy by Cdc13 or Est2, we used transformants (pRS425-GPD or pRS425-GPD-HSP82) of the CDC13-MYC9Â or EST2-MYC9Â yeast 23 . We determined fold enrichment by normalizing the ratio of specific to nonspecific signal (for example, a-Myc chromatin immunoprecipitation threshold cycle (C t value)/normal mouse IgG chromatin immunoprecipitation C t value) at the telomeric DNA targets to the ratio of specific to nonspecific signal produced by amplifying a nontelomeric region of the genome (YJL052W).
Telomere DNA length analysis. We prepared genomic DNA from yeast (YPH499) transformants (pRS425-GPD or pRS425-GPD-HSP82) after the indicated number of passages (B8-10 generations per passage). We digested the DNA overnight with XhoI, resolved it on a 25-cm 1% (w/v) agarose gel for 20-24 h at 40 V, and transferred it to an Immobilon-Ny + membrane (Millipore). We identified the telomeric DNA after hybridization in Ekono buffer (ISC BioExpress) supplemented with the radiolabeled telomeric oligonucleotide (TGTGGGT) 4 . As a loading and migration control, we used an established probe that recognizes a 1,621-nt fragment of chromosome IV (ref. 33). We generated the probe by PCR amplification of genomic DNA in the presence of a-dGTP using specific oligonucleotides (5¢-GTACCTCGGTTTAGTTAAGCG-3¢ and 5¢-CTCATTCGAATCCATACGACC-3¢). After appropriate washes using SSC and SDS buffers, we visualized the telomeric and control DNA using a PhosphorImager.
Telomere DNA extension assay. We conducted the telomere-elongation assay as described 22 . Three representative data sets are shown in Supplementary  Figure 5 . 
